If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells).

Trading Places is Stockhead’s recap of the substantial holder movements among ASX small caps over the last fortnight.

Substantial shareholders are those holding 5 per cent or more of a company’s shares — these can be directors, individual investors, or institutional investors.

Shareholders are required to announce to the exchange when they cross above or below the 5 per cent threshold, as well as any change in their holdings while they remain above 5 per cent.

 

Buyers

This week’s most notable move was made by Yarra Funds Management. It just surpassed 5 per cent ownership of Tasmanian salmon farmer Tassal (ASX:TGR) having accumulated $10.5 million in shares since last November.

Tassal has seen a volatile several months with solid sales in the domestic market but export markets were tough with supply chain and logistical issues. It still managed to make a profit of $27.6 million for the first half of FY21 – which was down from the prior corresponding period.

Speaking of new substantial shareholders, Los Angeles based Kayne Anderson Rudnick Investment has accumulated a 6 per cent stake in insurance software  giant Fineos (ASX:FCL) with a $16 million trade on March 10 taking it across the 5 per cent line.

And biological sample storer Cryosite (ASX:CTE) welcomed DMX Management, which has a 5.91 per cent stake having bought over $400,000 of stock in the last fortnight.

Exisiting substantial holders who bought more of their company were led by WiseTech (ASX:WTC) director Michael Gregg who bought another $1 million of Oliver’s Real Foods (ASX:OLI), taking his stake to 17 per cent.

Perennial Value Management upped its stake in employee wellness company Limeade (ASX:LME) to 13.7 per cent.

And Australian Ethical increased its holdings in resume verification software company CV Check (ASX:CV1) to 12 per cent.

 

Sellers

Andy Fung, the boss of digital communications technology company MNF Group (ASX:MNF) cut his stake to 13 per cent to purchase property and pay a tax bill – a sale that netted nearly $11 million.

Fidelity reduced its stake in ResApp Health (ASX:RAP) to just over 8 per cent – a move that came only a few days after Resapp signed a licensing deal with AstraZeneca.